BIOMEDICA MEDIZINPRODUKTE ROMANIA SRL secures contract for Peptic substances - antibodies and growth factors for fundamental high performance research within the HeartCure project (CF 93)

Romania, Jan. 30 -- Romania based BIOMEDICA MEDIZINPRODUKTE ROMANIA SRL has secured contract from Operator SEAP for Peptic substances - antibodies and growth factors for fundamental high performance research within the HeartCure project (CF 93). The value of the contract is worth 4085000 RON.

Published by HT Digital Content Services with permission from Pivotal Sources....